These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21421726)

  • 61. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.
    Kapur S; Seeman P
    Am J Psychiatry; 2001 Mar; 158(3):360-9. PubMed ID: 11229973
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.
    Mamo D; Graff A; Mizrahi R; Shammi CM; Romeyer F; Kapur S
    Am J Psychiatry; 2007 Sep; 164(9):1411-7. PubMed ID: 17728427
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.
    Kapur S; Zipursky RB; Remington G; Jones C; DaSilva J; Wilson AA; Houle S
    Am J Psychiatry; 1998 Jul; 155(7):921-8. PubMed ID: 9659858
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S; Zipursky RB; Remington G
    Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Estimated dopamine D₂ receptor occupancy and remission in schizophrenia: analysis of the CATIE data.
    Moriguchi S; Bies RR; Remington G; Suzuki T; Mamo DC; Watanabe K; Mimura M; Pollock BG; Uchida H
    J Clin Psychopharmacol; 2013 Oct; 33(5):682-5. PubMed ID: 23899638
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vivo serotonin 5-HT(2A) receptor occupancy and quetiapine.
    Jones HM; Travis MJ; Mulligan R; Visvikis D; Gacinovic S; Ell PJ; Kerwin RW; Pilowsky LS
    Am J Psychiatry; 2000 Jan; 157(1):148. PubMed ID: 10618043
    [No Abstract]   [Full Text] [Related]  

  • 67. Striatal Dopamine D2 Receptor Occupancy Induced by Daily Application of Blonanserin Transdermal Patches: Phase II Study in Japanese Patients With Schizophrenia.
    Nishibe H; Tateno A; Sakayori T; Yamamoto M; Kim W; Kakuyama H; Okubo Y
    Int J Neuropsychopharmacol; 2021 Feb; 24(2):108-117. PubMed ID: 32936897
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907.
    Hinz R; Bhagwagar Z; Cowen PJ; Cunningham VJ; Grasby PM
    J Cereb Blood Flow Metab; 2007 Jan; 27(1):161-72. PubMed ID: 16685260
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison between olanzapine and haloperidol on procedural learning and the relationship with striatal D2 receptor occupancy in schizophrenia.
    Paquet F; Soucy JP; Stip E; Lévesque M; Elie A; Bédard MA
    J Neuropsychiatry Clin Neurosci; 2004; 16(1):47-56. PubMed ID: 14990759
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of risperidone on high-affinity state of dopamine D2 receptors: a PET study with agonist ligand [11C](R)-2-CH3O-N-n-propylnorapomorphine.
    Kodaka F; Ito H; Takano H; Takahashi H; Arakawa R; Miyoshi M; Okumura M; Otsuka T; Nakayama K; Halldin C; Farde L; Suhara T
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):83-9. PubMed ID: 20860881
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antipsychotics, dopamine D₂ receptor occupancy and clinical improvement in schizophrenia: a meta-analysis.
    Yilmaz Z; Zai CC; Hwang R; Mann S; Arenovich T; Remington G; Daskalakis ZJ
    Schizophr Res; 2012 Sep; 140(1-3):214-20. PubMed ID: 22795368
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Positron emission tomography of in-vivo binding characteristics of atypical antipsychotic drugs. Review of D2 and 5-HT2 receptor occupancy studies and clinical response.
    Nyberg S; Nakashima Y; Nordström AL; Halldin C; Farde L
    Br J Psychiatry Suppl; 1996 May; (29):40-4. PubMed ID: 8733822
    [No Abstract]   [Full Text] [Related]  

  • 73. ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models.
    Gardell LR; Vanover KE; Pounds L; Johnson RW; Barido R; Anderson GT; Veinbergs I; Dyssegaard A; Brunmark P; Tabatabaei A; Davis RE; Brann MR; Hacksell U; Bonhaus DW
    J Pharmacol Exp Ther; 2007 Aug; 322(2):862-70. PubMed ID: 17519387
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dissociation in Pharmacokinetic Attenuation Between Central Dopamine D2 Receptor Occupancy and Peripheral Blood Concentration of Antipsychotics: A Systematic Review.
    Kurose S; Mimura Y; Uchida H; Takahata K; Kim E; Suzuki T; Mimura M; Takeuchi H
    J Clin Psychiatry; 2020 Jul; 81(5):. PubMed ID: 32726002
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Population pharmacokinetics and prediction of dopamine D2 receptor occupancy after multiple doses of RBP-7000, a new sustained-release formulation of risperidone, in schizophrenia patients on stable oral risperidone treatment.
    Laffont CM; Gomeni R; Zheng B; Heidbreder C; Fudala PJ; Nasser AF
    Clin Pharmacokinet; 2014 Jun; 53(6):533-43. PubMed ID: 24464285
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Analysis of D2 dopamine receptor occupancy with quantitative SPET using the high-affinity ligand [123I]epidepride: resolving conflicting findings.
    Erlandsson K; Bressan RA; Mulligan RS; Ell PJ; Cunningham VJ; Pilowsky LS
    Neuroimage; 2003 Jul; 19(3):1205-14. PubMed ID: 12880845
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Decreased frontal serotonin 5-HT 2a receptor binding index in deliberate self-harm patients.
    Audenaert K; Van Laere K; Dumont F; Slegers G; Mertens J; van Heeringen C; Dierckx RA
    Eur J Nucl Med; 2001 Feb; 28(2):175-82. PubMed ID: 11303887
    [TBL] [Abstract][Full Text] [Related]  

  • 78. 123I-5-I-R91150, a new single-photon emission tomography ligand for 5-HT2A receptors: influence of age and gender in healthy subjects.
    Baeken C; D'haenen H; Flamen P; Mertens J; Terriere D; Chavatte K; Boumon R; Bossuyt A
    Eur J Nucl Med; 1998 Dec; 25(12):1617-22. PubMed ID: 9871092
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Quetiapine extended-release versus immediate-release formulation: a positron emission tomography study.
    Mamo DC; Uchida H; Vitcu I; Barsoum P; Gendron A; Goldstein J; Kapur S
    J Clin Psychiatry; 2008 Jan; 69(1):81-6. PubMed ID: 18312041
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Therapeutic window for striatal dopamine D(2/3) receptor occupancy in older patients with schizophrenia: a pilot PET study.
    Uchida H; Suzuki T; Graff-Guerrero A; Mulsant BH; Pollock BG; Arenovich T; Rajji TK; Mamo DC
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):1007-16. PubMed ID: 25217025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.